SPONSOR: iMBA Inc.

INSTItute of Medical Business Advisors, Inc.

center

About the Institute of Medical Business Advisors, Inc

The Institute of Medical Business Advisors, Inc provides a team of experienced, senior level consultants led by iMBA Chief Executive Officer Dr. David Edward Marcinko MBA CMP™ MBBS [Hon] and President Hope Rachel Hetico RN MHA CMP™ to provide going contact with our clients throughout all phases of each project, with most of the communications between iMBA and the key client participants flowing through this Senior Team.  iMBA Inc., and its skilled staff of certified professionals have many years of significant experience, enjoy a national reputation in the healthcare consulting field, and are supported by an unsurpassed research and support staff of CPAs, MBAs, MPHs, PhDs, CMPs™, CFPs® and JDs to maintain a thorough and extensive knowledge of the healthcare environment. The iMBA team approach emphasizes providing superior service in a timely, cost-effective manner to our clients by working together to focus on identifying and presenting solutions for our clients’ unique, individual needs.

The iMBA Inc project team’s exclusive focus on the healthcare industry provides a unique advantage for our clients.  Over the years, our industry specialization has allowed iMBA to maintain instantaneous access to a comprehensive collection of healthcare industry-focused data comprised of both historically-significant resources as well as the most recent information available.  iMBA Inc’s specific, in-depth knowledge and understanding of the “value drivers” in various healthcare markets, in addition to the transaction marketplace for healthcare entities, will provide you with a level of confidence unsurpassed in the public health, health economics, management, administration, and financial planning and consulting fields.  iMBA Inc’s information resources and network of healthcare industry textbook resources enhanced by our professional consultants and research staff, ensure that the iMBA project team will maintain the highest level of knowledge regarding the current and future trends of the specific specialty market related to the project, as well as the healthcare industry overall, which serves as the “foundation” for each of our client engagements.

DIY Textbooks: https://medicalexecutivepost.com/2021/04/29/why-are-certified-medical-planner-textbooks-so-darn-popular/

INVITE DR. MARCINKO: https://medicalexecutivepost.com/dr-david-marcinkos-

CONTACT: Ann Miller RN MH

[Executive Director]

MarcinkoAdvisors@msn.com

770-448-0769

***

HOUSING: Affordability Down

By Staff Reporters

***

Housing affordability Getting Worse

Surging bond yields are playing out in a bad way in the housing market, where the average mortgage rate in the US jumped to 7.09%, its highest level since 2002, per Freddie Mac. Combine those eye-watering borrowing costs with an inventory crunch that’s driven up prices, and you get the worst housing affordability conditions in four decades, Bloomberg reports.

Roughly 75% of US homeowners have mortgage rates of less than 4%, according to JPMorgan, so you can imagine why no one is eager to move and pay upward of 7% on a new place.

***

COMMENTS APPRECIATED

Thank You

***

***

DAILY UPDATE: Visionary CFOs and the Markets

By Staff Reporters

***

***

Most CFOs think we’ll avoid a recession this year—and that confidence is shared by other members of the C-suite. That’s according to PwC’s August Pulse Survey, which found that only 8% of CFOs predict a recession within the next six months.

The survey polled more than 600 C-suite executives from a variety of public and private companies. Among all respondents just 17% strongly agreed there’d be a recession in the next 6 months—a sharp decline from October 2022, when 35% did. Economists, policymakers, and executives “see…the possibility of a soft landing,”

Wes Bricker, PwC US vice chair and trust co-leader, said during a media call. “It’s encouraging to see optimism from so many business leaders who participated in our survey.”

CITE: https://www.r2library.com/Resource

***

Here is where the major benchmarks ended:

  • The S&P 500® Index (SPX) rose 29 points (0.67%) to 4,405.71; the Dow Jones Industrial Average (DJIA) rose 248 points (0.73%) to 34,346.90; the NASDAQ Composite (COMP) rose 127 points (0.94%) to 13,590.65.
  • The 10-year Treasury note yield (TNX) was about 2 basis points lower at 4.226%.
  • CBOE’s Volatility Index (VIX) fell 1.5 points to 15.68.

Friday’s gains left the S&P 500 Index up less than 1% for the week, while the NASDAQ was 2.2% higher, thanks in part to a solid week for tech as investors positioned for the quarterly earnings report from Nvidia (NVDA), widely seen as a bellwether of the artificial intelligence industry. The Dow Jones Industrial Average was still about 0.44% lower, hurt in part by a stumble by Boeing (BA) Thursday.

Energy was the best-performing sector Friday, as crude oil futures rose about 1.2% after a week in the doldrums.

***

ORDER: https://www.routledge.com/Comprehensive-Financial-Planning-Strategies-for-Doctors-and-Advisors-Best/Marcinko-Hetico/p/book/9781482240283

***

COMMENTS APPRECIATED

Thank You

***

Health Care Entity: Venture Capital Funding

http://www.MARCINKOASSOCIATES.com

***

***

Venture capital funding in the digital health space cooled a bit in 2022 following a red-hot 2021. Overall, digital health companies raised $15.3 billion last year, down from the $29.1 billion raised in 2021—but still above the $14.1 billion raised in 2020, according to Rock Health a seed fund that supports digital health startups.

MORE: https://marcinkoassociates.com/fmv-appraisals/

Nevertheless, analysts predict VC investors and bankers will still put a good amount of money into digital health in 2024 and 2025, especially in alternative care, drug development, health information technology technology, EMRs and software that reduces physician workload.

CITE: https://www.r2library.com/Resource

Of course. an essential first part of attracting VC interest and money is the crafting and presentation of your formal business plan [“elevator pitch”]; as well as the needed technical and managerial experience. This is crucial for success and exactly where we can assist.

***

READ MORE: https://marcinkoassociates.com/welcome-medical-colleagues/

CONTACT: MarcinkoAdvisors@msn.com

***

***

PODCAST: CVS Replaces it’s PBM

Existential Threat to Pharmacy Benefits Managers?

By Staff Reporters

***

***

DEFINITION

***

Just now, CVS got a taste of its own medicine after Blue Shield of California said it will replace CVS’s pharmacy benefit manager system [PBMs] with other companies, including Amazon Pharmacy and Mark Cuban’s Cost Plugs Drugs business, to supply cheaper drugs to its members.

CITE: https://www.r2library.com/Resource

The move poses an existential threat to the entire pharmacy-benefit manager model.

***

COMMENTS APPRECIATED

Thank You

***

***

***